iShares Biotechnology ETF

iShares Biotechnology ETF

IBB

$215.47

Updated: 04/11/2026, 10:03:34

Market Cap
$11.37B
Sector
Financial Services
Industry
Asset Management
Country
US

No historical data available

Company Profile

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

USD
NASDAQ
https://www.ishares.com/us/products/239699/ishares-biotechnology-etf
Asset Summaries
Latest generated summaries for IBB

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for IBB.
Share price
$215.47
Market cap
$11.37B
Exchange
NASDAQ
Currency
USD
CEO
N/A
Employees
N/A
IPO date
12/02/2001
Beta
0.7
Last dividend
$0.00
Day range
$214.52 – $218.10
52-week range
$119.78 – $222.29
1-day performance
0.79%
1-year performance
79.89%
Current drawdown (1Y)
-3.07%
CIK
0001100663
CUSIP
464287556
ISIN
US4642875565
Created
07/12/2025, 04:38:20
Last update
04/11/2026, 10:03:34

Track iShares Biotechnology ETF with an AI analyst

See which prediction-market events move IBB, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.